Loading…
Loading…
Sentiment · FY2026 Q1
| Analyst | Firm | Questions | ChallengePercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|---|
| Dara Mohsenian | Morgan Stanley | 7 | 0% |
| Bonnie Herzog | Goldman Sachs | 7 | 14% |
| Mike Lavery | Piper Sandler | 6 | 0% |
| Chris Carey | Wells Fargo | 6 | 0% |
| Kaumil Gajrawala | Jefferies | 6 | 0% |
| Filippo Falorni | Citigroup | 6 | 0% |
| Peter Grom | UBS | 6 | 0% |
| Lauren Lieberman | Barclays | 6 | 50% |
| Steve Powers | Deutsche Bank | 6 | 17% |
| Kevin Grundy | BNP Paribas | 5 | 40% |
| Firm | Analysts | Questions | ChallengePercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|---|
| Morgan Stanley | 1 | 7 | 0% |
| Goldman Sachs | 1 | 7 | 14% |
| Citigroup | 1 | 6 | 0% |
| Deutsche Bank | 1 |
| 6 |
| 17% |
| Evercore ISI | 2 | 6 | 0% |
| Jefferies | 1 | 6 | 0% |
| JPMorgan | 2 | 6 | 17% |
| Wells Fargo | 1 | 6 | 0% |
PepsiCo delivered Q1 organic revenue growth of 2.6% with core EPS increasing 9% year-over-year. PFNA volume recovery was underway with shelf reset execution driving results. PBNA showed platform growth and portfolio expansion, and international business accelerated. Productivity and cost transformation programs continued. Management affirmed FY2026 guidance of 2-4% organic revenue growth with no change. Innovation pipeline and permissible portfolio expansion advanced. The Iran conflict tested supply chain resilience.
Demand | Competitive Dynamics | Revenue Growth | Pricing | Margin | Product Launch | Guidance Reliability | Capital Allocation | |
|---|---|---|---|---|---|---|---|---|
| 2024Q4 | 6 | 4 | 2 | 4 | 3 | 3 | 2 | 1 |
| 2025Q1 | 5 | 4 | 4 | 3 | 2 | 1 | 2 | 1 |
| 2025Q2 | 3 | 2 | 3 | 1 | 3 | 4 | 3 | 2 |
| 2025Q3 | 5 | 1 | 2 | 2 | 3 | 2 | 2 | 4 |
| 2025Q4 | 8 | 5 | 3 | 3 | 2 | 3 | 3 | 1 |
| 2026Q1 | 9 | 6 | 7 | 3 | 2 | 2 | 1 | 2 |
| '24Q4 | '25Q1 | '25Q2 | '25Q3 | '25Q4 | '26Q1 | |
|---|---|---|---|---|---|---|
| Demand | 6 | 5 | 3 | 5 | 8 | 9 |
| Competitive Dynamics | 4 | 4 | 2 | 1 | 5 | 6 |
| Revenue Growth | 2 | 4 | 3 | 2 | 3 | 7 |
| Pricing | 4 | 3 | 1 | 2 | 3 | 3 |
| Margin | 3 | 2 | 3 | 3 | 2 | 2 |
| Product Launch | 3 | 1 | 4 | 2 | 3 | 2 |
| Guidance Reliability | 2 | 2 | 3 | 2 | 3 | 1 |
| Capital Allocation | 1 | 1 | 2 | 4 | 1 | 2 |
| Company | Score | Trend | Rev YoY |
|---|---|---|---|
PEP PepsiCo | 7 | +8.5% | |
| CCEP Coca-Cola Europacific Partners | 6 | +0.2% | |
| KDP Keurig Dr Pepper | 6 | +9.4% | |
| KO The Coca-Cola Company | 9 | +12.1% | |
| MNST Monster Beverage | 8 | +26.9% |